Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.

Koetsveld, JPlatonov, A EKuleshov, KWagemakers, AHoornstra, DAng, WSzekeres, Svan Duijvendijk, G L AFikrig, EEmbers, M ESprong, HHovius, J W2019-10-212019-10-212019-08-091469-06913140467210.1016/j.cmi.2019.07.026http://hdl.handle.net/10029/623376eninfo:eu-repo/semantics/closedAccessBorrelia miyamotoi diseaseLyme diseaseRelapsing fever borreliosisSerodiagnosisSerologyBorrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.ArticleClin Microbiol Infect 2019; advance online publication (ahead of print)